Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial. - Chow DS; Nguyen A; Park J; Wu L; Toups EG; Harrop JS; Guest JD; Schmitt KM; Aarabi B; Fehlings MG; Boakye M; Grossman RG (Journal of neurotrauma, 2023)